ZNTL icon

Zentalis Pharmaceuticals
ZNTL

Overview Fund Activity

132 hedge funds and large institutions have $92.9M invested in Zentalis Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 42 increasing their positions, 49 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
132
Holders Change
-10
Holders Change %
-7.04%
% of All Funds
1.79%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
18
Increased
42
Reduced
49
Closed
27
Calls
$31K
Puts
$188K
Net Calls
-$157K
Net Calls Change
-$164K

Top Buyers

1
Millennium Management
Millennium Management
New York
+$3.36M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$2.55M
3
TCM
Tang Capital Management
California
+$2.39M
4
Bank of America
Bank of America
North Carolina
+$1.45M
5
PLC
Peapod Lane Capital
New York
+$888K

Top Sellers

1
EAM
Eventide Asset Management
Massachusetts
-$13.6M
2
Citadel Advisors
Citadel Advisors
Florida
-$5M
3
MB
MPM BioImpact
Massachusetts
-$3.35M
4
IHAM
Integral Health Asset Management
New York
-$3.18M
5
Verition Fund Management
Verition Fund Management
Connecticut
-$1.74M
Name Holding Trade Value Shares
Change 		Shares
Change %
OAM
151
Oxford Asset Management
United Kingdom
– -$51.9K -17,134 Closed
VA
152
Vident Advisory
Georgia
– -$44.6K -14,735 Closed
NRD
153
Nebula Research & Development
New York
– -$42.9K -14,167 Closed
CC
154
Corton Capital
Ontario, Canada
– -$31.5K -10,412 Closed
BIG
155
Brooklyn Investment Group
New York
– -$22.4K -7,402 Closed
CFGS
156
Concourse Financial Group Securities
Alabama
– -$226 -100 Closed
SAM
157
Smartleaf Asset Management
Massachusetts
– -$198 -68 Closed
IA
158
IFP Advisors
Florida
– -$70 -23 Closed
3 4 5 6
7